GLP-1 RASGLT2ifinerenonespironolactoneeplerenoneRAAS-Ilupus nephritis
…inuric LN, SGLT2i may be added after disease stabilization, and GLP-1 RA are reserved for those with type 2 diabetes. MRA use is not sta…
46articles mentioning drugs
415drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: SGLT2i ×
SGLT2i
This drug is selected. Its supporting articles are shown below.
Articles mentioning SGLT2i
46 articles · page 2 of 4SGLT2isSGLT2itype 2 diabetes mellitusEFSD/Boehringer Ingelheim European Research ProgrammeT2DM-ACS
…ACE and 6.7, 6.4, and 9.3 for first AKI respectively. Receiving SGLT2is at discharge significantly reduced the risk of MACE (hazard rat…
SGLT2iSGLT2isGLP-1RAsGLP-1RAtype 2 diabetesatherosclerotic cardiovascular diseasechronic kidney disease
… CI 47.2% to 54.7%) (8.2 million) met indications for either an SGLT2i or a GLP-1RA. Among those with indications for an SGLT2i specif…
SGLT2isodium–glucose co-transporter 2 inhibitorsCardiometabolic diseasechronic kidney diseasetype 2 diabetes mellitusheart failureSheffield Centre for Health and Related Research
…acist-led review. Overall, 32/75 patients (43%) were started on SGLT2i therapy according to guideline criteria. In the exploratory sub…
SGLT2isodium-glucose cotransporter 2 inhibitoreuDKAtype 2 diabetestype 5 myocardial infarction
…3 days prior to surgery compared with patients who discontinued SGLT2i 3–6 days before surgery. During the intraoperative period, pH <…
GLP-1RASGLT2i6974Biguanides9442Insulin10SGLT2iRChs-CRPTZDs2846Sulfonylureas1168
… history of receiving novel antidiabetic medications (SGLT2i or GLP-1RA). Sensitivity analyses were also conducted in participants with…
empagliflozindapagliflozinSGLT2iatrial fibrillationClinicalTrials.govHFpEFSGLT2 inhibitorsAFHFmrEF
…201276042) of RCTs comparing SGLT2 inhibitors (dapagliflozin or empagliflozin) against placebo in HFpEF (LVEF >40%). To minimise reporting bi…
GLP-1RASGLT2iglucagon-like peptide-1 receptor agonistssodium-glucose cotransporter-2 inhibitorstype 2 diabetesabove-target hemoglobin A1c
…tients to receive new SGLT2i (RR 0.59, 95% CI 0.42 to 0.82) and GLP-1RA (RR 0.62, 95% CI 0.49 to 0.79) prescriptions; Hispanic patients…
DapagliflozinSGLT2iChronic kidney disease-associated cardiomyopathyCKD-CMCKD-associated cardiomyopathy
…n renal interstitial fibrosis (p≤0.0001), compared to controls. Dapagliflozin attenuated serum BUN (p≤0.01) and creatinine (p≤0.01) but did n…
FinerenoneSGLT2isodium-glucose cotransporter 2 inhibitorsDiabetic kidney disease (DKD)end-stage renal diseasecardiovascular diseasePubMedCochrane LibraryChina National Knowledge InfrastructureEmbase+4 more
…arched. All randomised controlled clinical trials investigating Finerenone combined with SGLT2i for DKD treatment will be included. Data e…